Magnetic resonance-guided focused ultrasound therapy for symptomatic uterine fibroids.
D054598:Blue Cross Blue Shield Insurance Plans; D018795:Device Approval; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014464:Ultrasonic Therapy; D014481:United States; D014486:United States Food and Drug Administration; D014594:Uterine Neoplasms / Q000628:therapy*